Bruker Announces Launch of CE-IVD Marked genesig® Assay Kit for the Detection of the SARS-CoV-2 Virus
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Business Wire
Real-Time PCR kit validated for a variety of respiratory samples typesValidated with Bruker-Hain GenoXtract 12 DNA/ RNA extraction system and kitsAgreement signed with Primer Design LTD (UK), part of the Novacyt Group, for Bruker-Hain Diagnostics distribution of CE-IVD marked genesig® COVID-19 diagnostics kits NEHREN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced a distribution agreement with Primer Design Ltd (UK), a subsidiary of Novacyt SA, for Bruker-Hain Diagnostics to distribute the CE-IVD-labeled genesig® real-time PCR coronavirus (COVID-2019) assay, effective immediately. Bruker-Hain Diagnostics has a portfolio of DNA/RNA extraction and preparation systems and kits.The genesig® real-time PCR Coronavirus (COVID-2019) CE-IVD assay is validated for use on Bruker-Hain Diagnostics GenoXtract® (GXT) automated nucleic acid extraction devices with associated extraction kits. Shipments to Spain, France, Germany and the UK have already started.The genesi
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026Business Wire
- Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 [Yahoo! Finance]Yahoo! Finance
- Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak ManagementBusiness Wire
- Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026Business Wire
- Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
BRKR
Earnings
- 2/12/26 - Miss
BRKR
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form 144
- 4/10/26 - Form ARS
- BRKR's page on the SEC website